The Von Willebrand Factor Antigen Plasma Concentration: a Monitoring Marker in the Treatment of Aortic and Mitral Valve Diseases
Marco Alfonso Perrone(University of Rome Tor Vergata), Alessandro Terrinoni(University of Rome Tor Vergata), Renato Massoud(University of Rome Tor Vergata), Anna Copponi(Policlinico Tor Vergata), Marilena Minieri, F G Viola(Policlinico Tor Vergata), Giulia Maria Sancesario(Policlinico Tor Vergata), Silvia Angeletti(Università Campus Bio-Medico), Sergio Bernardini(University of Rome Tor Vergata), Francesco Romeo(University of Rome Tor Vergata), Sabrina Caporali(University of Rome Tor Vergata)
Cited by 4
Related Papers
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
|Alzheimer s & Dementia|2011|412
CSF biomarker variability in the Alzheimer's Association quality control program
|Alzheimer s & Dementia|2013|386
Microfluidic-enhanced 3D bioprinting of aligned myoblast-laden hydrogels leads to functionally organized myofibers in vitro and in vivo
|Biomaterials|2017|330
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
|The EMBO Journal|2005|261